Brainstorm Cell Therapeutics (BCLI) Misses Q1 EPS by 45c
Brainstorm Cell Therapeutics (NASDAQ: BCLI) reported Q1 EPS of ($0.45).
For earnings history and earnings-related data on Brainstorm Cell Therapeutics (BCLI) click here.
Brainstorm Cell Therapeutics (NASDAQ: BCLI) reported Q1 EPS of ($0.45).
For earnings history and earnings-related data on Brainstorm Cell Therapeutics (BCLI) click here.